Lactobacillus strains induce TRAIL production and facilitate natural killer activity against cancer cells

FEBS Letters

Volumn 584, Issue 3, 2010, Pages 577-582

  Horinaka, Mano ^a   Yoshida, Tatsushi ^a   Kishi, Atsuko ^b   Akatani, Kaoru ^b   Yasuda, Takashi ^a,c   Kouhara, Junji ^a   Wakada, Miki ^a   Sakai, Toshiyuki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Louis Pasteur Center for Medical Research   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cancer; Lactobacillus; Natural killer activity; TRAIL

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; PROBIOTIC AGENT; RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; CANCER CELL; CANCER CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LACTOBACILLUS PLANTARUM; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERFERON-ALPHA; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LACTOBACILLUS PLANTARUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, HELPER-INDUCER; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

LACTOBACILLUS;

EID: 74249085633     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.12.004     Document Type: Article

References (24)

1. Ashkenazi A., Pai R.C., Fong S., Leung S., Lawrence D.A., Marsters S.A., Blackie C., Chang L., McMurtrey A.E., Hebert A., DeForge L., Koumenis I.L., Lewis D., Harris L., Bussiere J., Koeppen H., Shahrokh Z., and Schwall R.H. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104 (1999) 155-162
2. Walczak H., Miller R.E., Ariail K., Gliniak B., Griffith T.S., Kubin M., Chin W., Jones J., Woodward A., Le T., Smith C., Smolak P., Goodwin R.G., Rauch C.T., Schuh J.C., and Lynch D.H. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5 (1999) 157-163
3. Ashkenazi A., and Herbst R.S. To kill a tumor cell: the potential of proapoptotic receptor agonists. J. Clin. Invest. 118 (2008) 1979-1990
4. Johnstone R.W., Frew A.J., and Smyth M.J. The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat. Rev. Cancer 8 (2008) 782-798
5. El-Deiry W.S. Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling. Cell Death Differ. 8 (2001) 1066-1075
6. Monleón I., Martínez-Lorenzo M.J., Monteagudo L., Lasierra P., Taulés M., Iturralde M., Piñeiro A., Larrad L., Alava M.A., Naval J., and Anel A. Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells. J. Immunol. 167 (2001) 6736-6744
7. Zerafa N., Westwood J.A., Cretney E., Mitchell S., Waring P., Iezzi M., and Smyth M.J. Cutting edge: TRAIL deficiency accelerates hematological malignancies. J. Immunol. 175 (2005) 5586-5590
8. Takeda K., and Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. J. Nutr. 137 (2007) 791S-793S
9. Takagi A., Matsuzaki T., Sato M., Nomoto K., Morotomi M., and Yokokura T. Inhibitory effect of oral administration of Lactobacillus casei on 3-methylcholanthrene-induced carcinogenesis in mice. Med. Microbiol. Immunol. 188 (1999) 111-116
10. de LeBlanc A., Matar C., LeBlanc N., and Perdigón G. Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Res. 7 (2005) R477-R486
11. Aso Y., Akaza H., Kotake T., Tsukamoto T., Imai K., and Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP study group. Eur. Urol. 27 (1995) 104-109
12. Ishikawa H., Akedo I., Otani T., Suzuki T., Nakamura T., Takeyama I., Ishiguro S., Miyaoka E., Sobue T., and Kakizoe T. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int. J. Cancer 116 (2005) 762-767
13. Hirose Y., Murosaki S., Yamamoto Y., Yoshikai Y., and Tsuru T. Daily intake of heat-killed Lactobacillus plantarum L-137 augments acquired immunity in healthy adults. J. Nutr. 136 (2006) 3069-3073
14. Murosaki S., Muroyama K., Yamamoto Y., and Yoshikai Y. Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing mice. Cancer Immunol. Immunother. 49 (2000) 157-164
15. Taniguchi H., Yoshida T., Horinaka M., Yasuda T., Goda A.E., Konishi M., Wakada M., Kataoka K., Yoshikawa T., and Sakai T. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Cancer Res. 68 (2008) 8918-8927
16. Tecchio C., Huber V., Scapini P., Calzetti F., Margotto D., Todeschini G., Pilla L., Martinelli G., Pizzolo G., Rivoltini L., and Cassatella M.A. IFN-α-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells. Blood 103 (2004) 3837-3844
17. Smyth M.J., Cretney E., Takeda K., Wiltrout R.H., Sedger L.M., Kayagaki N., Yagita H., and Okumura K. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis. J. Exp. Med. 193 (2001) 661-670
18. Miettinen M., Matikainen S., Vuopio-Varkila J., Pirhonen J., Varkila K., Kurimoto M., and Julkunen I. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect. Immun. 66 (1998) 6058-6062
19. Koga Y., Matsuzaki A., Suminoe A., Hattori H., and Hara T. Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils. Cancer Res. 64 (2004) 1037-1043
20. Gong B., and Almasan A. Genomic organization and transcriptional regulation of human Apo2/TRAIL gene. Biochem. Biophys. Res. Commun. 278 (2000) 747-752
21. Wang Q., Ji Y., Wang X., and Evers B.M. Isolation and molecular characterization of the 5′-upstream region of the human TRAIL gene. Biochem. Biophys. Res. Commun. 276 (2000) 466-471
22. Takagi A., Matsuzaki T., Sato M., Nomoto K., Morotomi M., and Yokokura T. Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis 22 (2001) 599-605
23. Horinaka M., Yoshida T., Shiraishi T., Nakata S., Wakada M., Nakanishi R., Nishino H., and Sakai T. The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells. Biochem. Biophys. Res. Commun. 333 (2005) 833-838
24. Horinaka M., Yoshida T., Shiraishi T., Nakata S., Wakada M., and Sakai T. The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand. Mol. Cancer Ther. 5 (2006) 945-951